戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  large B-cell lymphomas (centroblastic, 96%; immunoblastic, 4%).
2 tion of Epstein-Barr virus-infected B cells [immunoblastic and central nervous system (CNS) lymphoma]
3 rched for the normal in vivo counterparts of immunoblastic B-cell lymphoma (IL) that occurs in immuno
4 vo counterparts of immunosuppression-related/immunoblastic B-cell lymphoma (IL), which occurs in immu
5 rade non-Hodgkin's lymphomas (centroblastic, immunoblastic), but not in low-grade lymphomas (lymphocy
6        The protein is produced in the B cell immunoblastic cell line DS-1, in normal EBV-transformed
7 re composed of a uniform population of large immunoblastic cells with basophilic cytoplasm, centrally
8 SCF), 38 patients with intermediate-grade or immunoblastic high-grade non-Hodgkin's lymphoma who were
9  frequency of the prognostically unfavorable immunoblastic histology has decreased after HAART.
10 uded were diffuse large B cell, mantle cell, immunoblastic large B cell, follicular, posttransplant l
11 le skin sites (trunk, legs, disseminated) or immunoblastic large B-cell histology involving favorable
12                           Group III included immunoblastic large B-cell histology involving unfavorab
13 e lung transplant recipient who developed an immunoblastic lymphoma 4 months after lung transplantati
14 n thus be used safely to prevent EBV-related immunoblastic lymphoma after allogeneic marrow transplan
15 a distinctive morphology bridging large-cell immunoblastic lymphoma and anaplastic large-cell lymphom
16 ve prophylaxis and treatment of EBV-positive immunoblastic lymphoma in immunocompromised patients.
17 n-Barr virus (EBV) causes potentially lethal immunoblastic lymphoma in up to 25% of children receivin
18 R1 alterations lead to a striking extranodal immunoblastic lymphoma phenotype that mimics the human d
19 lly significant class of AIDS NHL designated immunoblastic lymphoma plasmacytoid (AIDS IBLP) lacks an
20  not receive prophylaxis and developed overt immunoblastic lymphoma responded fully to T-cell infusio
21                    We report the case of a B-immunoblastic lymphoma that developed in a pretransplant
22 newly diagnosed patients with large-cell and immunoblastic lymphoma who participated in prospective c
23  were 42 patients with intermediate-grade or immunoblastic lymphoma who were considered to be high (6
24 ansformed lymphoblastoid cell lines and AIDS immunoblastic lymphoma, and plasma cells, as defined by
25 bset of patients with intermediate-grade and immunoblastic lymphoma, the 3-year DFS was 89% (95% CI,
26 zation is consistent with that of large cell immunoblastic lymphoma.
27 h Working Formulation intermediate grade and immunoblastic lymphomas (exclusive of mantle cell) and s
28 sistent with previous findings in large cell immunoblastic lymphomas and indicates that this enzyme m
29 mphoma and most high-grade tumors, including immunoblastic lymphomas, expressed minimal amounts of hs
30 s, showed them to be most closely related to immunoblastic lymphomas, less so to plasmacytomas of Fas
31 c appearance of high-grade anaplastic/B-cell immunoblastic lymphomas, with loss of B-cell differentia
32 tologic subgroup, the large-cell diffuse and immunoblastic lymphomas.
33 iferative disorders to aggressive monoclonal immunoblastic lymphomas.
34 y also are B cell lymphomas, usually exhibit immunoblastic morphology, and contain Epstein-Barr virus
35 so found in cases with diffuse large cell or immunoblastic morphology.
36 one of three histologic subtypes: large-cell immunoblastic, small non-cleaved cell (Burkitt's or Burk
37 rwise specified (PTCL-NOS; n = 26) and angio-immunoblastic T-cell lymphoma (AITL; n = 46) patients tr